Nadrich & Cohen, LLP is currently pursuing Bard IVC Filter Lawsuit claims and investigating Inferior Vena Cava filters (IVCs) manufactured by C.R. Bard, Cook Medical, and Cordis. his product has been a problem for quite some time.
In August 2010 the US Food and Drug Administration (FDA) warned that from 2005 to 2010 that the FDA had received over 920 adverse event reports concerning the fracturing and migration of IVC filters after they were implanted.
Inferior Vena Cava Filters Are Used To Prevent Pulmonary Embolisms
Vena cava filters have been used by the medical community in the United States since the 1960s. C. R. Bard first obtained FDA clearance to market these devices more than a decade ago. IVC Filters are implanted in a major blood vessel called the inferior vena cava, and they are supposed to reduce a patient’s risk of death by preventing pulmonary embolisms (blood clot in the lungs). Unfortunately, they have been linked to many life-threatening complications.
The Bard retrievable IVC filter has been shown to have an accelerated failure risk and serious side effects. Studies have shown that the filter fractures and migrates in up to between 20 to 30% of patients use. Whereas other IVC devices have a much lower failure rate.
We Are Investigating IVC Filter Claims For Devices From These Manufacturers:
- C.R Bard
- Bard G2
- Bard Recovery
- Bard Eclipse
- Bard Recovery
- Cook Medical
- Cook Celect
- Cook Günther Tulipe
Serious IVC Complications can include:
- Device Fracture, Tilting, Migration
- Filter Perforation, Puncture or Damage
- Cardiac and Pericardial tamponade
- Cardiac arrhythmia
- Ventricle Tachycardia
- Caudal and Cephalad Migration
- Internal Bleeding
Adverse Reports and FDA Warnings For Bard IVC Devices
Surgeons implant retrievable Inferior Vena Cava filters (IVCs) in the veins of patients who are unable to take anticoagulants (blood thinners) in order to prevent blood clots from moving to the lungs. IVCs catch the clots in the blood stream and, over time, the clots dissipate. But the U.S. Food & Drug Administration (FDA) received hundreds of adverse reports about the retrievable filters. Reported complications included punctured organs, blood vessels and filter migration to different parts of the body.
In 2010, the FDA warned the retrievable filters posed risks of filter fracture, device migration, and organ perforation and should be removed as soon as the patient’s risk for blood clots subsided. The FDA updated safety communication in 2014, stating most devices should be removed between the 29th and 54th day after implantation. But the warning signs came too late for some. Plaintiffs began filing lawsuits across the country claiming the filters caused harm and death.
Contact The Bard IVC Filter Lawsuit Team Now For A Free Consultation
Nadrich & Cohen, LLP and its legal team are actively pursuing Bard IVC lawsuits. Our Defective Medical Device Team is also actively investigating IVC claims against Cook Medical and Cordis. Our team of lawyers has extensive experience pursuing defective medical device lawsuit claims and has recovered over $350,000,000 on behalf of injury victims and their families. If you or your loved one has suffered the side effect stated above because of the Bard Inferior Vena Cava filter, you may be entitled to financial recovery.
If you or your loved one has suffered the side effect stated above because of the Bard, Cook Medical or Cordis IVC filter you may be entitled to financial recovery. Call us now for a free case evaluation. The call is 100% confidential and free of charge. Don’t delay call 1-800-718-4658 now, use the live chat or complete the “Do I Have A Case?” form on this page.